HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and nine months ended December 31, ...
NEW YORK, NY / ACCESSWIRE / December 12, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. ("Taro" or ...
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) announced today that its CEO, Mr. Kal Sundaram, has informed Taro’s Board of Directors ...
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) is in the spotlight today after the company reported adjusted EPS of $2.68 on sales of $265.1 million for its fourth quarter of fiscal year 2016. Sales ...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback